Literature DB >> 17690839

Intracellular application of TNF-alpha impairs cell to cell communication via gap junctions in glioma cells.

Aiden Haghikia1, Kerstin Ladage, Pauline Lafênetre, Arash Haghikia, Daniel Hinkerohe, Dirk Smikalla, Claus G Haase, Rolf Dermietzel, Pedro M Faustmann.   

Abstract

Human gliomas are the most common class of brain neoplasm. In order to better characterize their response to inflammation, we evaluated the influence of tumor necrosis factor alpha (TNF-alpha) on the coupling behaviour and the membrane resting potential (MRP) of glioma cells (F98 glioma cell line) compared to primary astrocytes. In contrast to cultured primary astrocytes which exhibited a profound inhibition of gap junction mediated intercellular communication (GJIC), extracellular exposure of TNF-alpha to F98 glioma cells gained no effect on the functional coupling. Whereas, intracellular application of TNF-alpha into the glioma cells elicited similar effects as those found in primary astrocytes indicating a compromised accessibility of the TNF-alpha receptor in F98 cells. Western blotting, immunocytochemical staining and real time RT PCR analysis revealed a differential expression and distribution of TNF-alpha receptor 1 (TNFR1) in the glioma cells. Connexin 43 (Cx43) is the major astrocytic gap junction protein which when phosphorylated has been shown to reveal altered gating properties. Here we show that TNF-alpha increases the level of phosphorylated Cx43 in primary astrocytes but not in the F98 glioma cells. Our observations could account for the decreased regulatory effects of TNF-alpha on GJIC of F98 glioma cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690839     DOI: 10.1007/s11060-007-9462-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.506


  56 in total

1.  Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha.

Authors:  J G Norris; L P Tang; S M Sparacio; E N Benveniste
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

2.  p55 tumour necrosis factor receptors distribution in neuroblastoma cells.

Authors:  A M Chambaut-Guérin; C Rouher; X Gauthereau
Journal:  Neuroreport       Date:  1997-04-14       Impact factor: 1.837

3.  Direct gap junction communication between malignant glioma cells and astrocytes.

Authors:  W Zhang; W T Couldwell; M F Simard; H Song; J H Lin; M Nedergaard
Journal:  Cancer Res       Date:  1999-04-15       Impact factor: 12.701

4.  Effects of cytokines on microglial phenotypes and astroglial coupling in an inflammatory coculture model.

Authors:  Daniel Hinkerohe; Dirk Smikalla; Aiden Haghikia; Katharina Heupel; Claus G Haase; Rolf Dermietzel; Pedro M Faustmann
Journal:  Glia       Date:  2005-11-01       Impact factor: 7.452

5.  Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.

Authors:  Jan C Buckner; Karla V Ballman; John C Michalak; Gary V Burton; Terrence L Cascino; Paula J Schomberg; Roland B Hawkins; Bernd W Scheithauer; Howard M Sandler; Randolph S Marks; Judith R O'Fallon
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

6.  A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group.

Authors:  N Shand; F Weber; L Mariani; M Bernstein; A Gianella-Borradori; Z Long; A G Sorensen; N Barbier
Journal:  Hum Gene Ther       Date:  1999-09-20       Impact factor: 5.695

7.  Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes.

Authors:  D W Laird; K L Puranam; J P Revel
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

8.  Gene transfer to glial tumors using herpes simplex virus.

Authors:  Ajay Niranjan; Darren Wolfe; Wendy Fellows; William F Goins; Joseph C Glorioso; Douglas Kondziolka; L Dade Lunsford
Journal:  Methods Mol Biol       Date:  2004

9.  Phosphorylation of connexin 43 acts as a stimuli for proteasome-dependent degradation of the protein in lens epithelial cells.

Authors:  Henrique Girão; Paulo Pereira
Journal:  Mol Vis       Date:  2003-01-30       Impact factor: 2.367

10.  Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells.

Authors:  C Hao; F Beguinot; G Condorelli; A Trencia; E G Van Meir; V W Yong; I F Parney; W H Roa; K C Petruk
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

View more
  12 in total

Review 1.  Glial connexins and gap junctions in CNS inflammation and disease.

Authors:  Tammy Kielian
Journal:  J Neurochem       Date:  2008-04-10       Impact factor: 5.372

2.  Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma.

Authors:  Manmeet S Ahluwalia; Stephanie Bou-Anak; Monica E Burgett; Nehaw Sarmey; Divya Khosla; Saurabh Dahiya; Robert J Weil; Eunnyung Bae; Ping Huang; Mary McGraw; Lisa M Grove; Mitchell A Olman; Richard A Prayson; John H Suh; G Yancey Gillespie; Jill Barnholtz-Sloan; Amy S Nowacki; Gene H Barnett; Candece L Gladson
Journal:  J Neurooncol       Date:  2016-11-17       Impact factor: 4.130

3.  Neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity.

Authors:  Nikolay Karpuk; Maria Burkovetskaya; Teresa Fritz; Amanda Angle; Tammy Kielian
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

4.  Dexamethasone differentially regulates functional membrane properties in glioma cell lines and primary astrocytes in vitro.

Authors:  Daniel Hinkerohe; Dörte Wolfkühler; Aiden Haghikia; Carola Meier; Pedro M Faustmann; Uwe Schlegel
Journal:  J Neurooncol       Date:  2010-11-24       Impact factor: 4.130

Review 5.  Connexins, Pannexins and Gap Junctions in Perinatal Brain Injury.

Authors:  Alice McDouall; Kelly Q Zhou; Laura Bennet; Colin R Green; Alistair J Gunn; Joanne O Davidson
Journal:  Biomedicines       Date:  2022-06-18

Review 6.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

7.  Effect of chronic intracerebroventricluar administration of lipopolysaccharide on connexin43 protein expression in rat hippocampus.

Authors:  Mohammad Sayyah; Bahar Kaviani; Baharak Khoshkholgh-Sima; Marzieh Bagheri; Maryam Olad; Samira Choopani; Reza Mahdian
Journal:  Iran Biomed J       Date:  2012

Review 8.  Connexins and their channels in inflammation.

Authors:  Joost Willebrords; Sara Crespo Yanguas; Michaël Maes; Elke Decrock; Nan Wang; Luc Leybaert; Brenda R Kwak; Colin R Green; Bruno Cogliati; Mathieu Vinken
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-07-07       Impact factor: 8.250

9.  Cytokine effects on gap junction communication and connexin expression in human bladder smooth muscle cells and suburothelial myofibroblasts.

Authors:  Marco Heinrich; Andreas Oberbach; Nadine Schlichting; Jens-Uwe Stolzenburg; Jochen Neuhaus
Journal:  PLoS One       Date:  2011-06-02       Impact factor: 3.240

Review 10.  Gap junction proteins and their role in spinal cord injury.

Authors:  Ryan S Tonkin; Yilin Mao; Simon J O'Carroll; Louise F B Nicholson; Colin R Green; Catherine A Gorrie; Gila Moalem-Taylor
Journal:  Front Mol Neurosci       Date:  2015-01-06       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.